Il Dong Pharmaceutical Co Ltd (249420) — Cash Flow-to-Debt Ratio
Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of ₩11.28 Billion could theoretically repay 0% of its total liabilities (₩347.04 Billion) in one year. See Il Dong Pharmaceutical Co Ltd (249420) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Il Dong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Il Dong Pharmaceutical Co Ltd across 9 annual periods. Also explore how fast is Il Dong Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year debt coverage analysis for Il Dong Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Il Dong Pharmaceutical Co Ltd (249420) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩28.29 Billion | ₩429.99 Billion | ▲ +178.5% |
| 2023 | -0.08x | ₩-36.62 Billion | ₩437.00 Billion | ▲ +28.4% |
| 2022 | -0.12x | ₩-53.54 Billion | ₩457.59 Billion | ▼ -464.5% |
| 2021 | -0.02x | ₩-11.37 Billion | ₩548.39 Billion | ▼ -137.5% |
| 2020 | 0.06x | ₩19.37 Billion | ₩350.73 Billion | ▼ -52.0% |
| 2019 | 0.11x | ₩41.37 Billion | ₩359.83 Billion | ▼ -50.3% |
| 2018 | 0.23x | ₩66.65 Billion | ₩287.84 Billion | ▼ -12.2% |
| 2017 | 0.26x | ₩73.72 Billion | ₩279.55 Billion | ▲ +61.7% |
| 2016 | 0.16x | ₩45.98 Billion | ₩281.94 Billion | — |